Inactive Instrument

Bio-Works Technologies AB (publ) Share Price Nasdaq Stockholm

Equities

SE0007387089

Medical Equipment, Supplies & Distribution

Financials

Sales 2022 41.32M 3.89M 308M Sales 2023 43.9M 4.13M 327M Capitalization 277M 26.04M 2.06B
Net income 2022 -45M -4.23M -335M Net income 2023 -56M -5.27M -417M EV / Sales 2022 16.2 x
Net cash position 2022 65.88M 6.2M 491M Net cash position 2023 39.38M 3.71M 293M EV / Sales 2023 5.41 x
P/E ratio 2022
-16.4 x
P/E ratio 2023
-4.51 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 48.88%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Director of Finance/CFO - 31/07/23
Members of the board TitleAgeSince
Director/Board Member 50 14/05/20
Director/Board Member 61 17/05/18
Chairman 69 08/09/19
More insiders
Bio-Works Technologies AB is a Sweden-based biotechnology company. The Company designs, develops, manufactures and supplies products for purification and separation of proteins and other molecules for application in areas such as Research and Laboratory, Life Science and Biopharma, as well as Food and Beverage. The Company uses technology based on uses Agarose beads, which are derived from seaweed in the process of liquid chromatography and serve as adsorbers that bind molecules of interest allowing them to be recovered. Its product offerings, marketed under brand names WorkBeads, BabyBio and OptioBio, include Activated Resin for coupling ligands, BabyBio Columns for rapid protein purification and condition screening, Immobilized Metal-ion Affinity Chromatography (IMAC) Resin, Ion Exchange Chromatography (IEX) Resin and OptioBio Glass Columns for small-scale purification and screening, among others.
More about the company